The most commonly reported side effects of GLP-1 receptor agonists, documented across multiple large randomized controlled clinical trials enrolling thousands of participants, are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort, all of which are most commonly reported during the initial titration phase when dosage is being escalated from a low starting point toward a therapeutic target and the body is still adapting to the mechanism of action
These aren't vanity complaints
B12 supplementation improves nerve health and lethargy, making it easier to adhere to a diet and physical exercise when taking semaglutide
Importantly, research links lower glutathione status with age-related decline and higher health risk in older adultsmaking proactive, personalized support especially valuable over time
Does Retatrutide have long-term risks